Resveratrol potential fires interest in longevity drugs

Fri, 06 Jun 2008 06:59:56 -0400

Interest in longevity drugs continues to grow as new research points to the tonic effects of resveratrol. The New York Times notes that some scientists have become so enamored by the potential of the ingredient they have begun to take it in pill form. And the implications could be huge for any developer like Sirtris.

"The upside is so huge that if we are right, the company that dominates the sirtuin space could dominate the pharmaceutical industry and change medicine," said Dr. David Sinclair of the Harvard Medical School, a co-founder of the company.

- read the article in The New York Times

Baby Boomers drive Biotech

Maureen Martino — Mon, 19 Nov 2007 09:27:10 -0500

Baby Boomers are heading into their 50s--and they’re looking to biotechnology to not only to extend their lives, but to make their later years better. Unlike the Greatest Generation, which lived through the Depression and World War II, Baby Boomers are more affluent and control more wealth than any other generation in history. According to Paul Root Wolpe, president of the American Society for Bioethics and Humanities, a Boomer's median net worth grew to $107,000 in 2001--or $400,000, if home equity is included.

So how do they plan on spending that money? By pouring it in to the most innovative medical treatments money can buy in order to stave off aging. They’re advancing biotechnology, both by consuming biotech products and by investing in biotech and medical device companies that could make life-saving discoveries. Baby Boomers are demanding not just treatments, but cures, and their demands are expected to push the industry to new highs. Therapies for obesity, diabetes, cancer, cardiovascular disease and pain will be the biggest drivers of growth. While Baby Boomers won’t be getting any younger, they certainly don’t want to feel any older. “The boomers...have recast aging as a disease and death as a bad outcome,’ notes Wolpe.

- read this report for more

Aging

Resveratrol potential fires interest in longevity drugs

Baby Boomers drive Biotech